Markets

Biogen Canada Announces Broad Private Drug Plan Coverage For ZURZUVAE, Expanding Access For Eligible Patients With Postpartum Depression In Adults Following Childbirth

Nov 5, 2026 · 11:06 AM ET· updated 1h ago

Most national private drug plans now provide coverage for ZURZUVAE™, broadening access for eligible Canadian patients with private insurance coverage.Toronto, November 5, 2026 — Biogen Canada Inc. today announced that

Why It Matters

Biogen's postpartum depression medicine now gets covered by private insurance plans in Canada. This means more patients can afford it, which could help the company sell more.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BIIB247.57

-6.89 (-2.71%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.